Summary
Biogen Inc. filed an 8-K on October 26, 2016, to report its third-quarter financial results for the period ended September 30, 2016. This filing primarily references a press release (Exhibit 99.1) that contains the detailed operational and financial performance for the quarter. Investors should review this press release for specific figures related to revenue, earnings, and any forward-looking statements or guidance provided by the company. The information furnished in this report is crucial for understanding Biogen's ongoing financial health and performance trends, particularly in its key therapeutic areas.
Key Highlights
- 1Biogen announced its third-quarter 2016 financial results on October 26, 2016.
- 2The results are detailed in a press release furnished as Exhibit 99.1 to the 8-K filing.
- 3This filing serves as an update on the company's financial performance for the period ending September 30, 2016.
- 4Investors are directed to the press release for specific operational and financial details.
- 5The information is furnished, not filed, and therefore does not subject the company to Section 18 liabilities.
- 6This report is important for assessing Biogen's performance in its key business segments during Q3 2016.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly announce and provide access to Biogen Inc.'s financial results for the third quarter of 2016, which ended on September 30, 2016. The detailed results are presented in an accompanying press release.
The specific financial results, including revenue, earnings per share, and other key performance indicators, are contained within the press release that Biogen issued on October 26, 2016. This press release is attached to the 8-K filing as Exhibit 99.1.
While the 8-K itself does not detail forward-looking statements, the referenced press release (Exhibit 99.1) is likely to contain such information, including any guidance Biogen provided for future periods. Investors should carefully review the press release for any forward-looking statements and associated risks.
No, the press release furnished as part of this 8-K is specifically noted as being furnished pursuant to Item 2.02. This means it is not deemed 'filed' for purposes of Section 18 of the Exchange Act, nor is it subject to the liabilities of that section. It also won't be automatically incorporated into other SEC filings.